Shingles Vaccine

Shingles Vaccine Not Nearly Widely Used As Once Hoped.

On the front of its Science Times section, the New York Times (7/12, D1, Span, Subscription Publication) reports, "A combination of factors has dissuaded many physicians' offices and clinics from carrying Zostavax," the vaccine for shingles. At the same time, "its manufacturer, Merck, has been unable to produce sufficient quantities to meet even modest demand." As a result, "intermittent shortages that last months have kept the company from consistently marketing the vaccine and have forestalled public health campaigns that could have built awareness of the need for it." The article quoted epidemiologist Rafael Harpaz, MD, of the Centers for Disease Control and Prevention, as saying, "There hasn't been a single year since the vaccine was licensed in 2006 that there's been no problem with supply." Accordingly, only about 10% of people 60 years of age and older have received a shingles vaccination.

        The New York Times (7/11, Span, Subscription Publication) "The New Old Age" blog pointed out that the "Food and Drug Administration has since approved Zostavax for people aged 50 to 59." However, "the vaccine remains hard to find, cumbersome to get reimbursed for, and not nearly as widely used as researchers had hoped."

http://www.bobbybukamd.com/ http://www.drbobby.com/ http://www.wbderm.com/ http://www.williamsburgderm.com/

Shingles Vaccine

Shingles Vaccine Difficult To Find.

The AP (5/13) reported, "A vaccine exists to reduce the risk of shingles in certain age groups, but there are many obstacles to obtaining the shot." The "Food and Drug Administration approved the vaccine Zostavax in 2006 for use in people 60 and older, and earlier this year the agency OK'd the shot for ages 50 and up." However, "some medical facilities are waiting until action by the US Centers for Disease Control and Prevention before agreeing to provide the vaccine to people 50 to 59." The Advisory Committee on Immunization Practices, which makes vaccine recommendations to the agency, will discuss the topic next month. Also, physicians' offices often do not carry the vaccine because "the vaccine is covered under Medicare Part D (with some exceptions) but not Medicare Part B." Other obstacles include the high cost of the vaccine and supply shortages.

http://www.bobbybukamd.com/ http://www.drbobby.com/ http://www.wbderm.com/ http://www.williamsburgderm.com/